# aTYR PHARMA INC
> Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.
## Record
| Field | Value |
| --- | --- |
| Representation | alpha-profile-markdown-v4 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1:ro-d751713988987e9331980363e24189ce |
| Governance record representation | alpha-governance-record-v2 |
| Canonical entity | alpha:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52 |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/atyr-pharma-inc |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 26 |
| Claims under review | 1 |
| Evidence records | 6 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-10-22T04:47:15.090742+00:00 |
| Last reviewed | 2026-10-22T04:47:15.090742+00:00 |
## Identity
- Legal name: aTYR PHARMA INC
- Display name: aTYR PHARMA INC
## Alpha Governance Record
| Field | Value |
| --- | --- |
| Governance Record schema | alpha-governance-record-v2 |
| Ontology | alpha-governance-ontology-v1 |
| Record version | public-1:ro-d751713988987e9331980363e24189ce |
| As of | 2026-10-22T04:47:15.090742+00:00 |
| Completeness | 0.409 |
| Record Quality | 0.836 |
| Directors | 8 |
| Committees | 6 |
| Governance events | 16 |
| Entity class | public_company |
## Section coverage
| Section | State |
| --- | --- |
| identity | PUBLISHED |
| corporate_structure | NOT_REVIEWED |
| board | PUBLISHED |
| committees | PUBLISHED |
| leadership | PUBLISHED |
| ownership | NOT_REVIEWED |
| financials | NOT_REVIEWED |
| capital_structure | PUBLISHED |
| compensation | NOT_REVIEWED |
| governance | NOT_REVIEWED |
| shareholder_governance | NOT_REVIEWED |
| audit | NOT_REVIEWED |
| legal | NOT_REVIEWED |
| risk | NOT_REVIEWED |
| cyber | NOT_REVIEWED |
| ai_governance | NOT_REVIEWED |
| agent_governance | RESTRICTED |
| markets_external | NOT_REVIEWED |
| events | PUBLISHED |
| relationships | PUBLISHED |
| assessments | PUBLISHED |
| evidence | PUBLISHED |
## Board
- Eric Benevich: Director. Status: current. Independent: true. Since: 2024-01-01. claim_id=alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:5
- Jane A. Gross: Director. Status: current. Independent: true. Since: 2019-01-01. Committees: Compensation (chair); Compensation · Chair; Nominating and Governance (member); Nominating and Governance (member). claim_id=alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:6
- Paul Schimmel: Director. Status: current. Independent: true. Since: 2005-01-01. claim_id=alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:7
- Sanjay S. Shukla: Director. Status: current. Independent: false. Since: 2017-01-01. claim_id=alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:8
- Sara L. Zaknoen: Director. Status: current. Independent: true. Since: 2021-01-01. Committees: Compensation (member); Compensation; Nominating and Governance · Chair (member); Nominating and Governance (chair). claim_id=alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:9
- Steve Lucas: Director. Status: current. Independent: true. Since: 2019-01-01. Committees: Audit (chair); Audit · Chair; Nominating and Governance (member); Nominating and Governance (member). claim_id=alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:10
- Timothy P. Coughlin: Director. Status: current. Independent: true. Since: 2017-01-01. Committees: Audit (member). claim_id=alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:11
- Eric Benevich: Director (committee appointment). Status: unknown. Independent: NOT_PUBLISHED. Since: NOT_PUBLISHED. Committees: Audit (member); Compensation (member). claim_id=alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:committee_record:15
## Committees
- Audit (audit). Chair: Steve Lucas. Members: Steve Lucas (chair, current); Eric Benevich (member, current); Timothy P. Coughlin (member, current). committee_id=alpha:committee:atyr-pharma-inc:audit
- Audit · Chair; Nominating and Governance (audit). Chair: NOT_PUBLISHED. Members: Steve Lucas (member, current). committee_id=alpha:committee:atyr-pharma-inc:audit-chair-nominating-and-governance
- Compensation (compensation). Chair: Jane A. Gross. Members: Jane A. Gross (chair, current); Eric Benevich (member, current); Sara L. Zaknoen (member, current). committee_id=alpha:committee:atyr-pharma-inc:compensation
- Compensation · Chair; Nominating and Governance (compensation). Chair: NOT_PUBLISHED. Members: Jane A. Gross (member, current). committee_id=alpha:committee:atyr-pharma-inc:compensation-chair-nominating-and-governance
- Compensation; Nominating and Governance · Chair (compensation). Chair: NOT_PUBLISHED. Members: Sara L. Zaknoen (member, current). committee_id=alpha:committee:atyr-pharma-inc:compensation-nominating-and-governance-chair
- Nominating and Governance (nominating_governance). Chair: Sara L. Zaknoen. Members: Sara L. Zaknoen (chair, current); Jane A. Gross (member, current); Steve Lucas (member, current). committee_id=alpha:committee:atyr-pharma-inc:nominating-and-governance
## Executive leadership
- Jill M. Broadfoot: Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:12
- Nancy E. Denyes: General Counsel and Corporate Secretary [GC]. Status: current. claim_id=alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:13
- Sanjay S. Shukla, M.D., M.S.: President, Chief Executive Officer and Director [CEO]. Status: current. claim_id=alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:14
## Governance events
- CFO_CHANGED: Jill M. Broadfoot executive of aTYR PHARMA INC, effective 2026-03-26. Effective: 2026-03-26. Detected: 2026-10-22T04:47:15.090742+00:00. event_id=alpha:event:transition:64pdrlkl2m9d
- GC_CHANGED: Nancy E. Denyes executive of aTYR PHARMA INC, effective 2026-03-26. Effective: 2026-03-26. Detected: 2026-10-22T04:47:15.090742+00:00. event_id=alpha:event:transition:1yg5123jovw93
- CEO_CHANGED: Sanjay S. Shukla, M.D., M.S. executive of aTYR PHARMA INC, effective 2026-03-26. Effective: 2026-03-26. Detected: 2026-10-22T04:47:15.090742+00:00. event_id=alpha:event:transition:1ls7lnz11rcww5
- DIRECTOR_APPOINTED: Eric Benevich seat on aTYR PHARMA INC, effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-22T04:47:15.090742+00:00. event_id=alpha:event:transition:11906f15o1yhn
- DIRECTOR_APPOINTED: Sara L. Zaknoen seat on aTYR PHARMA INC, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-22T04:47:15.090742+00:00. event_id=alpha:event:transition:1hxullaolp8gm
- COMMITTEE_CREATED: Compensation; Nominating and Governance · Chair committee of aTYR PHARMA INC, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-22T04:47:15.090742+00:00. event_id=alpha:event:transition:kcruu417xe77e
- COMMITTEE_MEMBER_ADDED: Sara L. Zaknoen member of Compensation; Nominating and Governance · Chair, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-22T04:47:15.090742+00:00. event_id=alpha:event:transition:1xpmj6y1el3mp6
- DIRECTOR_APPOINTED: Jane A. Gross seat on aTYR PHARMA INC, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-22T04:47:15.090742+00:00. event_id=alpha:event:transition:122c62q1vfa5c2
- DIRECTOR_APPOINTED: Steve Lucas seat on aTYR PHARMA INC, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-22T04:47:15.090742+00:00. event_id=alpha:event:transition:1bie4mz5yoqq9
- COMMITTEE_CREATED: Audit · Chair; Nominating and Governance committee of aTYR PHARMA INC, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-22T04:47:15.090742+00:00. event_id=alpha:event:transition:8snwzd1fnrj3h
- COMMITTEE_MEMBER_ADDED: Steve Lucas member of Audit · Chair; Nominating and Governance, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-22T04:47:15.090742+00:00. event_id=alpha:event:transition:1ltduso1uqr0n4
- COMMITTEE_CREATED: Compensation · Chair; Nominating and Governance committee of aTYR PHARMA INC, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-22T04:47:15.090742+00:00. event_id=alpha:event:transition:19c6j4wyoa7rq
- COMMITTEE_MEMBER_ADDED: Jane A. Gross member of Compensation · Chair; Nominating and Governance, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-22T04:47:15.090742+00:00. event_id=alpha:event:transition:176z9v21ztrri
- DIRECTOR_APPOINTED: Sanjay S. Shukla seat on aTYR PHARMA INC, effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-22T04:47:15.090742+00:00. event_id=alpha:event:transition:1cnbcc0e1pkou
- DIRECTOR_APPOINTED: Timothy P. Coughlin seat on aTYR PHARMA INC, effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-22T04:47:15.090742+00:00. event_id=alpha:event:transition:z47qfyr66bg2
- DIRECTOR_APPOINTED: Paul Schimmel seat on aTYR PHARMA INC, effective 2005-01-01. Effective: 2005-01-01. Detected: 2026-10-22T04:47:15.090742+00:00. event_id=alpha:event:transition:1jcbcr61c0j7km
## Scoped resources
- `alpha://company/atyr-pharma-inc` (contract): https://registry.alpha.ac/api/public/companies/atyr-pharma-inc?format=record
- `alpha://company/atyr-pharma-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/atyr-pharma-inc?format=record§ion=identity
- `alpha://company/atyr-pharma-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/atyr-pharma-inc?format=record§ion=corporate-structure
- `alpha://company/atyr-pharma-inc/board` (contract): https://registry.alpha.ac/api/public/companies/atyr-pharma-inc?format=record§ion=board
- `alpha://company/atyr-pharma-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/atyr-pharma-inc?format=record§ion=committees
- `alpha://company/atyr-pharma-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/atyr-pharma-inc?format=record§ion=leadership
- `alpha://company/atyr-pharma-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/atyr-pharma-inc?format=record§ion=ownership
- `alpha://company/atyr-pharma-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/atyr-pharma-inc?format=record§ion=financials
- `alpha://company/atyr-pharma-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/atyr-pharma-inc?format=record§ion=capital-structure
- `alpha://company/atyr-pharma-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/atyr-pharma-inc?format=record§ion=compensation
- `alpha://company/atyr-pharma-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/atyr-pharma-inc?format=record§ion=governance
- `alpha://company/atyr-pharma-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/atyr-pharma-inc?format=record§ion=shareholder-governance
- `alpha://company/atyr-pharma-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/atyr-pharma-inc?format=record§ion=audit
- `alpha://company/atyr-pharma-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/atyr-pharma-inc?format=record§ion=legal
- `alpha://company/atyr-pharma-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/atyr-pharma-inc?format=record§ion=risk
- `alpha://company/atyr-pharma-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/atyr-pharma-inc?format=record§ion=cyber
- `alpha://company/atyr-pharma-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/atyr-pharma-inc?format=record§ion=ai-governance
- `alpha://company/atyr-pharma-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/atyr-pharma-inc?format=record§ion=agents
- `alpha://company/atyr-pharma-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/atyr-pharma-inc?format=record§ion=ecosystem
- `alpha://company/atyr-pharma-inc/events` (contract): https://registry.alpha.ac/api/public/companies/atyr-pharma-inc?format=record§ion=events
- `alpha://company/atyr-pharma-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/atyr-pharma-inc?format=record§ion=relationships
- `alpha://company/atyr-pharma-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/atyr-pharma-inc?format=record§ion=assessments
- `alpha://company/atyr-pharma-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/atyr-pharma-inc?format=record§ion=evidence
## Role modules
- NOT_ASSERTED
## Attention
- NO_RECORDS_FOUND
## Committee data
- Claim alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:committee_appointment:16: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:svetlana-lucas","name":"Steve Lucas"},"source_id":"board_seats"}`
- Claim alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:committee_appointment:17: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:eric-benevich","name":"Eric Benevich"},"source_id":"board_seats"}`
- Claim alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:committee_appointment:18: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:timothy-p-coughlin","name":"Timothy P. Coughlin"},"source_id":"board_seats"}`
- Claim alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:committee_appointment:20: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:jane-a-gross","name":"Jane A. Gross"},"source_id":"board_seats"}`
- Claim alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:eric-benevich","name":"Eric Benevich"},"source_id":"board_seats"}`
- Claim alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:committee_appointment:22: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:sara-l-zaknoen","name":"Sara L. Zaknoen"},"source_id":"board_seats"}`
- Claim alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:committee_appointment:24: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:sara-l-zaknoen","name":"Sara L. Zaknoen"},"source_id":"board_seats"}`
- Claim alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:committee_appointment:25: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:jane-a-gross","name":"Jane A. Gross"},"source_id":"board_seats"}`
- Claim alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:committee_appointment:26: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:svetlana-lucas","name":"Steve Lucas"},"source_id":"board_seats"}`
## Leadership
- Eric Benevich: Director. Claim: alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:5. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8073b388e47d621917490c30cc503c10331ec7645f4a53419e34a3bb2468c15c.
- Jane A. Gross: Director, Compensation · Chair; Nominating and Governance. Claim: alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:6. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8073b388e47d621917490c30cc503c10331ec7645f4a53419e34a3bb2468c15c.
- Paul Schimmel: Director. Claim: alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:7. Valid from: 2005-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8073b388e47d621917490c30cc503c10331ec7645f4a53419e34a3bb2468c15c.
- Sanjay S. Shukla: Director. Claim: alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:8. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8073b388e47d621917490c30cc503c10331ec7645f4a53419e34a3bb2468c15c.
- Sara L. Zaknoen: Director, Compensation; Nominating and Governance · Chair. Claim: alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:9. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8073b388e47d621917490c30cc503c10331ec7645f4a53419e34a3bb2468c15c.
- Steve Lucas: Director, Audit · Chair; Nominating and Governance. Claim: alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:10. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8073b388e47d621917490c30cc503c10331ec7645f4a53419e34a3bb2468c15c.
- Timothy P. Coughlin: Director, Audit. Claim: alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:11. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8073b388e47d621917490c30cc503c10331ec7645f4a53419e34a3bb2468c15c.
- Jill M. Broadfoot: Chief Financial Officer. Claim: alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:12. Valid from: 2026-03-26. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b339c7a87b83316b65065271fc7631856ceea79838a867cef7d9d700327cfb56.
- Nancy E. Denyes: General Counsel and Corporate Secretary. Claim: alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:13. Valid from: 2026-03-26. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d3d2cd3b48727f1f75f1e71caa91278ff34702e60bd27d77aeffb9f8c17bbb40.
- Sanjay S. Shukla, M.D., M.S.: President, Chief Executive Officer and Director. Claim: alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:14. Valid from: 2026-03-26. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:156fb0a061d6a7e3f81b62113d75820c2a6d14698585d5c95063b4760ab33b40.
## Roles
- PUBLISHED
## Governance
- NOT_ASSERTED
## Board committees
- Audit: Chair Steve Lucas; Members Steve Lucas (Chair); Eric Benevich; Timothy P. Coughlin. Claim: alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:committee_record:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:01b1343c8e0e5ae5e79074eaa16b41f067d28995fa2f07a6929e49d736431992.
- Compensation: Chair Jane A. Gross; Members Jane A. Gross (Chair); Eric Benevich; Sara L. Zaknoen. Claim: alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:committee_record:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:01b1343c8e0e5ae5e79074eaa16b41f067d28995fa2f07a6929e49d736431992.
- Nominating and Governance: Chair Sara L. Zaknoen; Members Sara L. Zaknoen (Chair); Jane A. Gross; Steve Lucas. Claim: alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:committee_record:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:01b1343c8e0e5ae5e79074eaa16b41f067d28995fa2f07a6929e49d736431992.
## Financials
- NOT_ASSERTED
## Workforce
- NOT_ASSERTED
## Market and index context
- PUBLISHED
## Legal Name
- aTYR PHARMA INC. Claim: alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dc6616385a62a3f2b2cd348d9b6bae4d18749b5e72ea11c51951e4a705f800a8.
## Entity Status
- Public listing published. Claim: alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dc6616385a62a3f2b2cd348d9b6bae4d18749b5e72ea11c51951e4a705f800a8.
## Published Fact
- US. Claim: alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dc6616385a62a3f2b2cd348d9b6bae4d18749b5e72ea11c51951e4a705f800a8.
## Committee Appointment
- Steve Lucas: chair, Audit. Claim: alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:committee_appointment:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:01b1343c8e0e5ae5e79074eaa16b41f067d28995fa2f07a6929e49d736431992.
- Eric Benevich: member, Audit. Claim: alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:committee_appointment:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:01b1343c8e0e5ae5e79074eaa16b41f067d28995fa2f07a6929e49d736431992.
- Timothy P. Coughlin: member, Audit. Claim: alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:committee_appointment:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:01b1343c8e0e5ae5e79074eaa16b41f067d28995fa2f07a6929e49d736431992.
- Jane A. Gross: chair, Compensation. Claim: alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:committee_appointment:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:01b1343c8e0e5ae5e79074eaa16b41f067d28995fa2f07a6929e49d736431992.
- Eric Benevich: member, Compensation. Claim: alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:01b1343c8e0e5ae5e79074eaa16b41f067d28995fa2f07a6929e49d736431992.
- Sara L. Zaknoen: member, Compensation. Claim: alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:01b1343c8e0e5ae5e79074eaa16b41f067d28995fa2f07a6929e49d736431992.
- Sara L. Zaknoen: chair, Nominating and Governance. Claim: alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:committee_appointment:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:01b1343c8e0e5ae5e79074eaa16b41f067d28995fa2f07a6929e49d736431992.
- Jane A. Gross: member, Nominating and Governance. Claim: alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:committee_appointment:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:01b1343c8e0e5ae5e79074eaa16b41f067d28995fa2f07a6929e49d736431992.
- Steve Lucas: member, Nominating and Governance. Claim: alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:committee_appointment:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:01b1343c8e0e5ae5e79074eaa16b41f067d28995fa2f07a6929e49d736431992.
## Security Listing
- ATYR (NASDAQ). Claim: alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:security_listing:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dc6616385a62a3f2b2cd348d9b6bae4d18749b5e72ea11c51951e4a705f800a8.
## Coverage states
| Field | Value |
| --- | --- |
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | PUBLISHED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |
## Public sources
- alpha:projection-evidence:dc6616385a62a3f2b2cd348d9b6bae4d18749b5e72ea11c51951e4a705f800a8: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/atyr-pharma-inc).
- alpha:projection-evidence:document:8073b388e47d621917490c30cc503c10331ec7645f4a53419e34a3bb2468c15c: [aTYR PHARMA INC DEF 14A 2026-03-26](https://www.sec.gov/Archives/edgar/data/1339970/000133997026000021/atyr-20260326.htm).
- alpha:projection-evidence:document:b339c7a87b83316b65065271fc7631856ceea79838a867cef7d9d700327cfb56: [ATYR DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1339970/000133997026000021/atyr-20260326.htm).
- alpha:projection-evidence:document:d3d2cd3b48727f1f75f1e71caa91278ff34702e60bd27d77aeffb9f8c17bbb40: [ATYR DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1339970/000133997026000021/atyr-20260326.htm).
- alpha:projection-evidence:document:156fb0a061d6a7e3f81b62113d75820c2a6d14698585d5c95063b4760ab33b40: [ATYR DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1339970/000133997026000021/atyr-20260326.htm).
- alpha:projection-evidence:01b1343c8e0e5ae5e79074eaa16b41f067d28995fa2f07a6929e49d736431992: [Audit](https://www.sec.gov/Archives/edgar/data/1339970/000133997026000021/atyr-20260326.htm).
## Rights
| Field | Value |
| --- | --- |
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |
## Limitations
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.
## Alternate representations
- [Canonical profile](https://registry.alpha.ac/companies/atyr-pharma-inc)
- [Public Markdown](https://registry.alpha.ac/companies/atyr-pharma-inc.md)
- [Public JSON](https://registry.alpha.ac/api/public/companies/atyr-pharma-inc?format=record)
- [JSON-LD](https://registry.alpha.ac/api/public/companies/atyr-pharma-inc?format=jsonld)
- MCP resource: `alpha://companies/atyr-pharma-inc` at https://mcp.alpha.ac/mcp
## Connected governance records
Structured intelligence is not currently available. Existing published profile evidence remains accessible.
## Critical-risk oversight
Snapshot as of 2026-10-22T11:44:52.879906+00:00; recorded 2026-10-22T11:44:52.879906+00:00. Every published assignment for this snapshot is listed.
Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording.
An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.aTYR PHARMA INC, for agents
The same record as the human view, as a structured object any agent can read and cite. Reading is open to every agent, model, and tool, with no key and no account. Signing and transparency logging are not yet published for this record.
- Alpha ID
- alpha:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52
- Version
- vpublic-1:ro-d751713988987e9331980363e24189ceRecorded Oct 22, 2026
- Content hash
- Not yet signed
- Signature
- Not yet signed
- Transparency log
- Not yet signed
- Freshness
- ObservedChecked Oct 22, 2026. Reviewed Oct 22, 2026
- Read access
- OpenNo key for public retrieval
- Processing basis
- Public recordDoctrine
Read
OpenOne canonical URL. The Accept header or a file suffix selects the format. Every format renders the same Claims and carries the same record version.
curl -H "Accept: application/json" https://registry.alpha.ac/companies/atyr-pharma-incTrustCheck and Governance Receipts
Agent tierIllustrative. TrustChecks run in the private enterprise overlay. The example below is generated for this entity class and does not reference this record. Contract: TrustCheck and Governance Receipts v0.1.
Agents about to act ask a question, not for a document. A TrustCheck evaluates the AuthorityGrant objects behind a proposed action and returns allow, deny, require_approval, or insufficient_evidence. The source system acts, and a GovernanceReceipt records what the agent relied on.
- allow, deny
- The AuthorityGrant and policy decide. Reason codes name the rule.
- require_approval
- An entitled human records the decision. Customer policy sets the threshold, never an Eval.
- insufficient_evidence
- No authority is registered. Alpha never infers permission to act.
curl https://www.alpha.ac/v1/action-intents \
-H 'Content-Type: application/json' \
-b "$ALPHA_SESSION_COOKIE" \
-d '{
"schema_version": "2026-08-29",
"environment": "test",
"actor": { "alpha_id": "alpha:account:self", "type": "alpha_account" },
"principal": { "alpha_id": "alpha:company:example-issuer", "type": "organization" },
"organization": { "alpha_id": "alpha:company:example-issuer", "type": "organization" },
"proposed_action": { "type": "purchase_order.commit", "description": "Accept an order placed by an agent claiming company authority." },
"requested_authority": ["purchase_order.commit"]
}'
# then
curl https://www.alpha.ac/v1/trust-checks -H 'Content-Type: application/json' \
-b "$ALPHA_SESSION_COOKIE" -d '{ "action_intent_id": "<from the previous response>" }'{
"schema_version": "2026-08-29",
"trust_check_id": "alpha:trust-check:illustrative-0001",
"decision": "insufficient_evidence",
"explanation": "No AuthorityGrant names this agent and organization.",
"reason_codes": [
"authority_grant_missing"
],
"evaluated_authority": {
"authority_grants": []
},
"policy_version": "trustcheck.registry-claim.test.v0.1",
"integrity_state": "recorded",
"limitations": [
"Illustrative example. No TrustCheck was run for this record."
]
}{
"schema_version": "2026-08-29",
"receipt_id": "alpha:receipt:illustrative-0001",
"environment": "test",
"actor": {
"alpha_id": "alpha:account:self",
"type": "alpha_account"
},
"agent": {
"provider": {
"alpha_id": "alpha:company:example-agent-provider",
"type": "provider"
},
"product": {
"alpha_id": "alpha:agent-product:example-procurement-agent",
"type": "agent_product"
},
"deployment": {
"alpha_id": "alpha:agent-deployment:example-deployment",
"type": "agent_deployment"
},
"use_case": {
"alpha_id": "alpha:agent-use-case:example-purchase-order",
"type": "agent_use_case"
},
"workflow": "Illustrative purchase order commitment"
},
"principal": {
"alpha_id": "alpha:company:example-issuer",
"type": "organization"
},
"sponsor": {
"alpha_id": "alpha:company:example-issuer",
"type": "organization"
},
"action_intent_id": "alpha:action-intent:illustrative-0001",
"trust_check_id": "alpha:trust-check:illustrative-0001",
"authority_grant_references": [],
"action_intent": {
"type": "purchase_order.commit"
},
"affected_alpha_ids": [
"alpha:company:example-issuer"
],
"trust_check_decision": "insufficient_evidence",
"policy_version": "trustcheck.registry-claim.test.v0.1",
"rule_references": [
{
"reason_code": "authority_grant_missing",
"rule_id": "trustcheck.authority_grant_missing",
"policy_ref": "trustcheck.registry-claim.test.v0.1",
"control_ref": null,
"grant_policy_references": []
}
],
"integrity": "Illustrative. Not issued, not signed."
}Connect
Open readEvery surface reads the same published record. No surface holds its own copy of the facts.
// claude_desktop_config.json, Cursor, or any MCP client
{
"mcpServers": {
"alpha": { "url": "https://mcp.alpha.ac/mcp" }
}
}
// This record as an MCP resource
alpha://companies/atyr-pharma-incalpha://companies/atyr-pharma-incThis record as an MCP resourcehttps://registry.alpha.ac/api/public/companies/atyr-pharma-inc?format=recordThe same record over HTTP
Subscribe to changes
Agent tier, previewNo public subscription endpoint is published yet. Event delivery is part of Agent tier access, in preview. Access and availability.
CFO_CHANGEDDerived governance event published on this record (alpha-governance-event-derivation-v2)GC_CHANGEDDerived governance event published on this record (alpha-governance-event-derivation-v2)CEO_CHANGEDDerived governance event published on this record (alpha-governance-event-derivation-v2)DIRECTOR_APPOINTEDDerived governance event published on this record (alpha-governance-event-derivation-v2)COMMITTEE_CREATEDDerived governance event published on this record (alpha-governance-event-derivation-v2)COMMITTEE_MEMBER_ADDEDDerived governance event published on this record (alpha-governance-event-derivation-v2)
{
"specversion": "1.0",
"type": "ac.alpha.registry.CFO_CHANGED",
"source": "https://registry.alpha.ac/companies/atyr-pharma-inc",
"subject": "alpha:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52",
"data": {
"record_version": "public-1:ro-d751713988987e9331980363e24189ce",
"note": "Subscription delivery is Agent tier, preview. Not yet available publicly."
}
}Versions and changes
OpenRecords are versioned. Derived governance events on this record are listed below with the version that publishes them. Effective is the world time the derivation states; Recorded is when Alpha detected the event. Content hashes and log entries appear once records are signed.
| Version | Effective | Recorded | Content hash | Log entry | What changed |
|---|---|---|---|---|---|
| vpublic-1:ro-d751713988987e9331980363e24189ce | Mar 26, 2026 | Oct 22, 2026 | Not yet signed | Not yet signed | Jill M. Broadfoot executive of aTYR PHARMA INC, effective 2026-03-26. |
| vpublic-1:ro-d751713988987e9331980363e24189ce | Mar 26, 2026 | Oct 22, 2026 | Not yet signed | Not yet signed | Nancy E. Denyes executive of aTYR PHARMA INC, effective 2026-03-26. |
| vpublic-1:ro-d751713988987e9331980363e24189ce | Mar 26, 2026 | Oct 22, 2026 | Not yet signed | Not yet signed | Sanjay S. Shukla, M.D., M.S. executive of aTYR PHARMA INC, effective 2026-03-26. |
| vpublic-1:ro-d751713988987e9331980363e24189ce | Jan 1, 2024 | Oct 22, 2026 | Not yet signed | Not yet signed | Eric Benevich seat on aTYR PHARMA INC, effective 2024-01-01. |
| vpublic-1:ro-d751713988987e9331980363e24189ce | Jan 1, 2021 | Oct 22, 2026 | Not yet signed | Not yet signed | Sara L. Zaknoen seat on aTYR PHARMA INC, effective 2021-01-01. |
| vpublic-1:ro-d751713988987e9331980363e24189ce | Jan 1, 2021 | Oct 22, 2026 | Not yet signed | Not yet signed | Compensation; Nominating and Governance · Chair committee of aTYR PHARMA INC, effective 2021-01-01. |
| vpublic-1:ro-d751713988987e9331980363e24189ce | Jan 1, 2021 | Oct 22, 2026 | Not yet signed | Not yet signed | Sara L. Zaknoen member of Compensation; Nominating and Governance · Chair, effective 2021-01-01. |
| vpublic-1:ro-d751713988987e9331980363e24189ce | Jan 1, 2019 | Oct 22, 2026 | Not yet signed | Not yet signed | Jane A. Gross seat on aTYR PHARMA INC, effective 2019-01-01. |
| vpublic-1:ro-d751713988987e9331980363e24189ce | Jan 1, 2019 | Oct 22, 2026 | Not yet signed | Not yet signed | Steve Lucas seat on aTYR PHARMA INC, effective 2019-01-01. |
| vpublic-1:ro-d751713988987e9331980363e24189ce | Jan 1, 2019 | Oct 22, 2026 | Not yet signed | Not yet signed | Audit · Chair; Nominating and Governance committee of aTYR PHARMA INC, effective 2019-01-01. |
| vpublic-1:ro-d751713988987e9331980363e24189ce | Jan 1, 2019 | Oct 22, 2026 | Not yet signed | Not yet signed | Steve Lucas member of Audit · Chair; Nominating and Governance, effective 2019-01-01. |
| vpublic-1:ro-d751713988987e9331980363e24189ce | Jan 1, 2019 | Oct 22, 2026 | Not yet signed | Not yet signed | Compensation · Chair; Nominating and Governance committee of aTYR PHARMA INC, effective 2019-01-01. |
| vpublic-1:ro-d751713988987e9331980363e24189ce | Jan 1, 2019 | Oct 22, 2026 | Not yet signed | Not yet signed | Jane A. Gross member of Compensation · Chair; Nominating and Governance, effective 2019-01-01. |
| vpublic-1:ro-d751713988987e9331980363e24189ce | Jan 1, 2017 | Oct 22, 2026 | Not yet signed | Not yet signed | Sanjay S. Shukla seat on aTYR PHARMA INC, effective 2017-01-01. |
| vpublic-1:ro-d751713988987e9331980363e24189ce | Jan 1, 2017 | Oct 22, 2026 | Not yet signed | Not yet signed | Timothy P. Coughlin seat on aTYR PHARMA INC, effective 2017-01-01. |
| vpublic-1:ro-d751713988987e9331980363e24189ce | Jan 1, 2005 | Oct 22, 2026 | Not yet signed | Not yet signed | Paul Schimmel seat on aTYR PHARMA INC, effective 2005-01-01. |
Access, rights, and the public-role doctrine
Facts are open. Rights travel with every Claim and every Evidence record, so an agent sees the same terms whichever format it reads.
| Capability | Access | Agents |
|---|---|---|
| Alpha Disclosure sample | public | human process |
| Alpha public website | public | retrievable now |
| Alpha Standard, methodology, and research | public | retrievable now |
| Alpha Profiles (public executive and company records) | public | retrievable now |
| Public HTTP endpoints described by OpenAPI 3.1 | public | retrievable now |
| Alpha MCP public discovery and read-only capabilities | public | retrievable now |
| Alpha AI Readiness Eval | public | human process |
| Alpha Platform | approved access | requires approved access |
| Alpha API (authenticated operations) | approved access | requires approved access |
| Alpha MCP premium capabilities | approved access | requires approved access |
| Alpha Evals and verified assessments | custom | human process |
| Alpha Council membership | custom | human process |
| Alpha Institute education, workshops, and coaching | custom | human process |
| Governance diagnostics and institutional advisory | custom | human process |
Record limitations. Every representation states these in the same words; nothing is inferred as zero.
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.
"rights": {
"public_retrieval": "allowed",
"agent_retrieval": "allowed",
"redistribution": "not_granted",
"model_training": "not_granted",
"commercial_use": "not_specified",
"relationship_pathfinding": "not_granted",
"direct_contact": "not_granted"
}
"evidence_rights": {
"evidence_records": 6,
"redistribution_allowed": 0,
"restricted_or_unknown": 6,
"classified_unknown": 6
}"data_subject": {
"basis": "public_record",
"entity": "alpha:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52",
"identity_ownership": "unclaimed",
"rights": {
"public_retrieval": "allowed",
"agent_retrieval": "allowed",
"redistribution": "not_granted",
"model_training": "not_granted",
"commercial_use": "not_specified",
"relationship_pathfinding": "not_granted",
"direct_contact": "not_granted"
},
"requests": "https://www.alpha.ac/contact"
}How agents find this
OpenThe page head and every response carry rel="alternate" links and the Registry's Link header. The list below is generated from the same list the server emits.
/llms-full.txtAlpha consolidated public agent guide/.well-known/ai-catalog.jsonAlpha Agentic Resource Discovery manifest/.well-known/api-catalogapi-catalog/.well-known/webmcp.jsonAlpha WebMCP tool discovery/openapi.jsonAlpha Governance Public Intelligence API (OpenAPI 3.1)/apiAlpha Intelligence API/developersAlpha Governance Developer Platform/docs/trustcheck-receipts-v01.mdTrustCheck and Governance Receipts v0.1 test preview/docs/apiAlpha service documentation/llms.txtAlpha service docs for AI agents/agents.mdAlpha agent instructions (when to use Alpha)/api-versioning.mdAlpha public API versioning and deprecation policy/.well-known/agent-skills/index.jsonAgent Skills Index/products/accessAlpha Access and Availability/api/public/product-accessAlpha Product Access and Availability JSON/api/public/auth-capabilitiesAlpha Authentication Capabilities JSON/peopleAlpha Executive Profiles/companiesAlpha Company Profiles/people/readinessAlpha Profile Coverage and Agent Readiness/api/public/profile-readinessAlpha Public Profile Readiness JSON/api/public/profiles/steven-wolfe-pereiraAlpha Public Profile JSON Example/.well-known/agent-card.jsonA2A Agent Card/.well-known/mcp/server-card.jsonMCP Server Card/.well-known/openid-configurationOpenID Configuration/.well-known/oauth-protected-resourceOAuth Protected Resource/.well-known/oauth-authorization-serverOAuth Authorization Server (agent_auth)/.well-known/agent-registrationAgent Registration/.well-known/http-message-signatures-directoryhttp-message-signatures-directory/.well-known/jwks-rotationJWKS Rotation Policy/auth.mdAgent Authentication/llms.txtSite overview for AI agents/sitemap.xmlsitemap/api/public/agent-readinessAgent Readiness Status/api/public/company-report/osw-market-dataOSW Market Data Verification
Record map and assertion states
| Section | Anchor | Resource | State | Claims |
|---|---|---|---|---|
| Identity | #c-subject | /identity | Published | 0 |
| Corporate structure | - | /corporate_structure | Not reviewed | - |
| Board | #c-board | /board | Published | 8 |
| Committees | #c-committees | /committees | Published | 12 |
| Leadership | #c-leadership | /leadership | Published | 2 |
| Ownership | #c-control | /ownership | Not reviewed | 0 |
| Financials | #c-financials | /financials | Not reviewed | 1 |
| Capital structure | - | /capital_structure | Published | - |
| Compensation | #c-comp | /compensation | Not reviewed | 0 |
| Governance | #c-governance | /governance | Not reviewed | 0 |
| Shareholder governance | - | /shareholder_governance | Not reviewed | - |
| Audit | - | /audit | Not reviewed | - |
| Legal | #c-legal | /legal | Not reviewed | 0 |
| Risk | #c-risk | /risk | Not reviewed | 0 |
| Cyber | - | /cyber | Not reviewed | - |
| AI governance | #c-ai | /ai_governance | Not reviewed | 0 |
| Agent governance | #c-authority | /agent_governance | Restricted | 0 |
| Markets external | - | /markets_external | Not reviewed | - |
| Events | #c-history | /events | Published | 16 |
| Relationships | #c-links | /relationships | Published | 11 |
| Assessments | #c-monitor | /assessments | Published | 0 |
| Evidence | #c-evidence | /evidence | Published | 6 |
- corroboratedTwo or more independent sources agree
- source_reportedOne cited source states it
- alpha_inferenceAlpha's conclusion, with reasoning
- not_disclosedSearched, nothing found. Never rendered as false
- not_reviewedNot yet searched
- not_registeredNo authority registered with Alpha



